SELLAS Life Sciences Group, Inc.
SLSBiotechnology
$10.16−2.17%As of Oct 29vs prior close
- Market cap
- $2.1B
- P/E (TTM)
- –
- From 52W high
- −34.31%
- EPS (LTM)
- -$0.21
- Revenue (YE23)
- $0
Nomior Score
65
Steady ProfileSpeculativeTop 16% of the scored universe
Growth—
Quality53
Value—
Momentum99
Resilience45
Growth
$0revenue, YE23
YE19 $0YE23 $0
Connections
Revenue to profitYE22
The operating loss was 4195% of revenue, wider by 3862 pts on a year.
Who owns it
2funds